APA (7th ed.) Citation

Z, X., Z, Y., Z, S., S, H., & F, X. (2026). Preliminary evaluation of a DDA cationic liposome-based pulmonary mucosal immunization platform carrying a SARS-CoV-2 spike-derived branched peptide. Frontiers in immunology, 17, 1824741. https://doi.org/10.3389/fimmu.2026.1824741

Chicago Style (17th ed.) Citation

Z, Xia, Yang Z, Shi Z, Huang S, and Xu F. "Preliminary Evaluation of a DDA Cationic Liposome-based Pulmonary Mucosal Immunization Platform Carrying a SARS-CoV-2 Spike-derived Branched Peptide." Frontiers in Immunology 17 (2026): 1824741. https://doi.org/10.3389/fimmu.2026.1824741.

MLA (9th ed.) Citation

Z, Xia, et al. "Preliminary Evaluation of a DDA Cationic Liposome-based Pulmonary Mucosal Immunization Platform Carrying a SARS-CoV-2 Spike-derived Branched Peptide." Frontiers in Immunology, vol. 17, 2026, p. 1824741, https://doi.org/10.3389/fimmu.2026.1824741.